Taurine reduces inflammatory responses after spinal cord injury

Journal of Neurotrauma

Volumn 27, Issue 2, 2010, Pages 403-410

  Nakajima, Yasuhiro ^a   Osuka, Koji ^b   Seki, Yukio ^c   Gupta, Ramesh C ^d   Hara, Masahito ^a   Takayasu, Masakazu ^b   Wakabayashi, Toshihiko ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI MEDICAL UNIVERSITY   (Japan)

^c NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^d NAGALAND UNIVERSITY   (India)

Author keywords

Interleukin 6; Myeloperoxidase; Spinal cord injury; Taurine

Indexed keywords

CYCLOOXYGENASE 2; INTERLEUKIN 6; MYELOPEROXIDASE; SODIUM CHLORIDE; STAT3 PROTEIN; TAURINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CENTRAL NERVOUS SYSTEM; COMPRESSION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAY MATTER; IMMUNOHISTOCHEMISTRY; MOTOR DYSFUNCTION; MOUSE; NERVOUS SYSTEM INFLAMMATION; NEUTROPHIL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SINGLE DRUG DOSE; SPINAL CORD INJURY; SUBARACHNOID SPACE; THERAPY EFFECT; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOTTING, WESTERN; CYCLOOXYGENASE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; INFLAMMATION; INTERLEUKIN-6; MICE; MICE, INBRED C57BL; NEUTROPHIL INFILTRATION; PEROXIDASE; PHOSPHORYLATION; SPINAL CORD INJURIES; STAT3 TRANSCRIPTION FACTOR; TAURINE;

EID: 77649171822     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2009.1044     Document Type: Article

References (52)

1. Adachi, K., Yimin, Y., Satake, K., Matsuyama, Y., Ishiguro, N., Sawada, M., Hirata, Y., and Kiuchi, K. (2005). Localization of cyclooxygenase-2 induced following traumatic spinal cord injury. Neurosci. Res. 51, 73-80.
2. Azuma, J. (1994). Long-term effect of taurine in congestive heart failure: preliminary report. Heart Failure Research with Taurine Group. Adv. Exp. Med. Biol. 359, 425-433.
3. Barone, F.C., Hillegass, L.M., Price, W.J., White, R.F., Lee, E.V., Feuerstein, G.Z., Sarau, H.M., Clark, R.K., and Griswold, D.E. (1991). Polymorphonuclear leukocyte infiltration into cerebral focal ischemic tissue: myeloperoxidase activity assay and histologic verification. J. Neurosci. Res. 29, 336-345.
4. Benton, R.L., Ross, C.D., and Miller, K.E. (2001). Spinal taurine levels are increased 7 and 30 days following methylprednisolone treatment of spinal cord injury in rats. Brain Res. 893, 292-300.
5. Bracken, M.B., Shepard, M.J., Collins, W.F., Holford, T.R., Young, W., Baskin, D.S., Eisenberg, H.M., Flamm, E., Leo-Summers, L., and Maroon, J. (1990). A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N. Engl. J. Med. 322, 1405-1411.
6. Bracken, M.B., Shepard, M.J., Holford, T.R., Leo-Summers, L., Aldrich, E.F., Fazl, M., Fehlings, M., Herr, D.L., Hitchon, P.W., Marshall, L.F., Nockels, R.P., Pascale, V., Perot, P.L. Jr., Piepmeier, J., Sonntag, V.K., Wagner, F., Wilberger, J.E., Winn, H.R., and Young, W. (1997). Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. JAMA 277, 1597-1604.
7. Carlson, S.L., Parrish, M.E., Springer, J.E., Doty, K., and Dossett, L. (1998). Acute inflammatory response in spinal cord following impact injury. Exp. Neurol. 151, 77-88.
8. Chen, X.C., Pan, Z.L., Liu, D.S., and Han, X. (1998). Effect of taurine on human fetal neuron cells: proliferation and differentiation. Adv. Exp. Med. Biol. 442, 397-403.
9. Diaz-Ruiz, A., Salgado-Ceballos, H., Montes, S., Maldonado, V., Tristan, L., Alcaraz-Zubeldia, M., and Rios, C. (2007). Acute alterations of glutamate, glutamine, GABA, and other amino acids after spinal cord contusion in rats. Neurochem. Res. 32, 57-63.
10. El Idrissi, A., and Trenkner, E. (1999). Growth factors and taurine protect against excitotoxicity by stabilizing calcium homeostasis and energy metabolism. J. Neurosci. 19, 9459-9468.
11. El Idrissi, A. (2008). Taurine increases mitochondrial buffering of calcium: role in neuroprotection. Amino Acids 34, 321-328.
12. Farooque, M., Hillered, L., Holtz, A., and Olsson, Y. (1996). Changes of extracellular levels of amino acids after graded compression trauma to the spinal cord: an experimental study in the rat using microdialysis. J. Neurotrauma 13, 537-548.
13. Farooque, M. (2000). Spinal cord compression injury in the mouse: presentation of a model including assessment of motor dysfunction. Acta Neuropathol. 100, 13-22.
14. Faulkner, J.R., Herrmann, J.E., Woo, M.J., Tansey, K.E., Doan, N.B., and Sofroniew, M.V. (2004). Reactive astrocytes protect tissue and preserve function after spinal cord injury. J. Neurosci. 24, 2143-2155.
15. Fukuda, K., Hirai, Y., Yoshida, H., Nakajima, T., and Usui, T. (1982). Free amino acid content of lymphocytes and granulocytes compared. Clin. Chem. 28, 1758-1761.
16. Georganas, C., Liu, H., Perlman, H., Hoffmann, A., Thimmapaya, B., and Pope, R.M. (2000). Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts: the dominant role for NF-kappa B but not C=EBP beta or c-Jun. J. Immunol. 165, 7199-7206.
17. Giri, S.N., and Wang, Q. (1992). Taurine and niacin offer a novel therapeutic modality in prevention of chemically-induced pulmonary fibrosis in hamsters. Adv. Exp. Med. Biol. 315, 329-340.
18. Gupta, R.C., Seki, Y., and Yosida, J. (2006). Role of taurine in spinal cord injury. Curr. Neurovasc. Res. 3, 225-235.
19. Gupta, R.C., Win, T., and Bittner, S. (2005). Taurine analogues; a new class of therapeutics: retrospect and prospects. Curr. Med. Chem. 12, 2021-2039.
20. Hayashi, M., Ueyama, T., Nemoto, K., Tamaki, T., and Senba, E. (2000). Sequential mRNA expression for immediate early genes, cytokines, and neurotrophins in spinal cord injury. J. Neurotrauma 17, 203-218.
21. Heinrich, P.C., Behrmann, I., Muller-Newen, G., Schaper, F., and Graeve, L. (1998). Interleukin-6-type cytokine signalling through the gp130=Jak=STAT pathway. Biochem. J. 334 (Pt. 2), 297-314.
22. Huxtable, R.J. (1992). Physiological actions of taurine. Physiol. Rev. 72, 101-163.
23. Kamencic, H., Griebel, R.W., Lyon, A.W., Paterson, P.G., and Juurlink, B.H. (2001). Promoting glutathione synthesis after spinal cord trauma decreases secondary damage and promotes retention of function. FASEB J. 15, 243-250.
24. Kim, C., Park, E., Quinn, M.R., and Schuller-Levis, G. (1996). The production of superoxide anion and nitric oxide by cultured murine leukocytes and the accumulation of TNF-alpha in the conditioned media is inhibited by taurine chloramine. Immunopharmacology 34, 89-95.
25. Kontny, E., Grabowska, A., Kowalczewski, J., Kurowska, M., Janicka, I., Marcinkiewicz, J., and Maslinski, W. (1999). Taurine chloramine inhibition of cell proliferation and cytokine production by rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheum. 42, 2552-2560.
26. Kontny, E., Szczepanska, K., Kowalczewski, J., Kurowska, M., Janicka, I., Marcinkiewicz, J., and Maslinski, W. (2000). The mechanism of taurine chloramine inhibition of cytokine (interleukin-6, interleukin-8) production by rheumatoid arthritis fibroblast-like synoviocytes. Arthritis Rheum. 43, 2169-2177.
27. Lake, N. (1992). Taurine, GABA and GFAP immunoreactivity in the developing and adult rat optic nerve. Brain Res. 596, 124-132.
28. Lee, I.S., Renno, W.M., and Beitz, A.J. (1992). A quantitative light and electron microscopic analysis of taurine-like immunoreactivity in the dorsal horn of the rat spinal cord. J. Comp. Neurol. 321, 65-82.
29. Lehmann, A., and Hansson, E. (1987). Amino acid content in astroglial primary cultures from different brain regions during cultivation. Neurochem. Res. 12, 797-800.
30. Lima, L., Matus, P., and Drujan, B. (1988). Taurine effect on neuritic growth from goldfish retinal explants. Int. J. Dev. Neurosci. 6, 417-424.
31. Marcinkiewicz, J., Grabowska, A., Bereta, J., and Stelmaszynska, T. (1995). Taurine chloramine, a product of activated neutrophils, inhibits in vitro the generation of nitric oxide and other macrophage inflammatory mediators. J. Leukoc. Biol. 58, 667-674.
32. Marcinkiewicz, J., Grabowska, A., Bereta, J., Bryniarski, K., and Nowak, B. (1998). Taurine chloramine down-regulates the generation of murine neutrophil inflammatory mediators. Immunopharmacology 40, 27-38.
33. McAdoo, D.J., Xu, G.Y., Robak, G., and Hughes, M.G. (1999). Changes in amino acid concentrations over time and space around an impact injury and their diffusion through the rat spinal cord. Exp. Neurol. 159, 538-544.
34. Milei, J., Ferreira, R., Llesuy, S., Forcada, P., Covarrubias, J., and Boveris, A. (1992). Reduction of reperfusion injury with preoperative rapid intravenous infusion of taurine during myocardial revascularization. Am. Heart J. 123, 339-345.
35. Pan, J.Z., Ni, L., Sodhi, A., Aguanno, A., Young, W., and Hart, R.P. (2002). Cytokine activity contributes to induction of inflammatory cytokine mRNAs in spinal cord following contusion. J. Neurosci. Res. 68, 315-322.
36. Pasantes-Morales, H., and Schousboe, A. (1989). Release of taurine from astrocytes during potassium-evoked swelling. Glia 2, 45-50.
37. Resnick, D.K., Graham, S.H., Dixon, C.E., and Marion, D.W. (1998). Role of cyclooxygenase 2 in acute spinal cord injury. J. Neurotrauma 15, 1005-1013.
38. Streit, W.J., Semple-Rowland, S.L., Hurley, S.D., Miller, R.C., Popovich, P.G., and Stokes, B.T. (1998). Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis. Exp. Neurol. 152, 74-87.
39. Sun, M., and Xu, C. (2008). Neuroprotective mechanism of taurine due to up-regulating calpastatin and down-regulating calpain and caspase-3 during focal cerebral ischemia. Cell Mol. Neurobiol. 28, 593-611.
40. Takatani, T., Takahashi, K., Uozumi, Y., Matsuda, T., Ito, T., Schaffer, S.W., Fujio, Y., and Azuma, J. (2004). Taurine prevents the ischemia-induced apoptosis in cultured neonatal rat cardiomyocytes through Akt=caspase-9 pathway. Biochem. Biophys. Res. Commun. 316, 484-489. (Pubitemid 38338617)
41. Taoka, Y., Okajima, K., Murakami, K., Johno, M., and Naruo, M. (1998). Role of neutrophil elastase in compression-induced spinal cord injury in rats. Brain Res. 799, 264-269. (Pubitemid 28351256)
42. Taoka, Y., Okajima, K., Uchiba, M., Murakami, K., Kushimoto, S., Johno, M., Naruo, M., Okabe, H., and Takatsuki, K. (1997). Role of neutrophils in spinal cord injury in the rat. Neuroscience 79, 1177-1182.
43. Tator, C.H., and Fehlings, M.G. (1991). Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J. Neurosurg. 75, 15-26.
44. Tatsumi, T., and Fliss, H. (1994). Hypochlorous acid and chloramines increase endothelial permeability: possible involvement of cellular zinc. Am. J. Physiol. 267, H1597-H1607.
45. Tonai, T., Shiba, K., Taketani, Y., Ohmoto, Y., Murata, K., Muraguchi, M., Ohsaki, H., Takeda, E., and Nishisho, T. (2001). A neutrophil elastase inhibitor (ONO-5046) reduces neurologic damage after spinal cord injury in rats. J. Neurochem. 78, 1064-1072.
46. Wang, C.X., Nuttin, B., Heremans, H., Dom, R., and Gybels, J. (1996a). Production of tumor necrosis factor in spinal cord following traumatic injury in rats. J. Neuroimmunol. 69, 151-156.
47. Wang, G.H., Jiang, Z.L., Fan, X.J., Zhang, L., Li, X., and Ke, K.F. (2007). Neuroprotective effect of taurine against focal cerebral ischemia in rats possibly mediated by activation of both GABAA and glycine receptors. Neuropharmacology 52, 1199-1209.
48. Wang, J.H., Redmond, H.P., Watson, R.W., Condron, C., and Bouchier-Hayes, D. (1996b). The beneficial effect of taurine on the prevention of human endothelial cell death. Shock 6, 331-338.
49. Xuan, Y.T., Guo, Y., Zhu, Y., Han, H., Langenbach, R., Dawn, B., and Bolli, R. (2003). Mechanism of cyclooxygenase-2 upregulation in late preconditioning. J. Mol. Cell Cardiol. 35, 525-537.
50. Xu, J.A., Hsu, C.Y., Liu, T.H., Hogan, E.L., Perot, P.L. Jr., and Tai, H.H. (1990). Leukotriene B4 release and polymorphonuclear cell infiltration in spinal cord injury. J. Neurochem. 55, 907-912.
51. Yamauchi, K., Osuka, K., Takayasu, M., Usuda, N., Nakazawa, A., Nakahara, N., Yoshida, M., Aoshima, C., Hara, M., and Yoshida, J. (2006). Activation of JAK=STAT signalling in neurons following spinal cord injury in mice. J. Neurochem. 96, 1060-1070.
52. Yang, L., Blumbergs, P.C., Jones, N.R., Manavis, J., Sarvestani, G.T., and Ghabriel, M.N. (2004). Early expression and cellular localization of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in human traumatic spinal cord injury. Spine 29, 966-971.